FLEMING JONATHAN 4
4 · Radius Health, Inc. · Filed Nov 22, 2011
Insider Transaction Report
Form 4
FLEMING JONATHAN
Director
Transactions
- Award
Series A-1 Convertible Preferred Stock
2011-11-18$81.42/sh+16,214$1,320,144→ 32,427 total(indirect: By Fund)From: 2011-11-18→ Common Stock (162,140 underlying) - Award
Series A-1 Convertible Preferred Stock
2011-11-18$81.42/sh+162$13,190→ 324 total(indirect: By Fund)From: 2011-11-18→ Common Stock (1,620 underlying)
Footnotes (3)
- [F1]Each share of the Series A-1 Convertible Preferred Stock has no expiration date and is convertible at any time, in whole or in part, at the election of the holder at a conversion rate of 10 shares of Common Stock for every 1 share of Series A-1 Convertible Preferred Stock.
- [F2]The reported securities are owned directly by OBP IV - Holdings LLC ("OBP IV"). OBP Management IV, L.P. ("OBP Management IV") is the sole general partner of Oxford Bioscience Partners IV, L.P. ("OBP LP"), a member of OBP IV. The reporting person is one of two individual general partners of OBP Management IV. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- [F3]The reported securities are owned directly by mRNA II - Holdings LLC ("mRNA II"). OBP Management IV is the sole general partner of mRNA Fund II, L.P. ("mRNA LP"), a member of mRNA II. The reporting person is one of two individual general partners of OBP Management IV. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.